[Updated 11/16/17, 10:47 am. See below.] Dave Balter, a serial entrepreneur and startup investor in the Boston area, has stepped down as CEO of one of his latest ventures, Mylestone.
Balter has shifted to the role of chairman, and... Read more »
The immune system can’t fight disease if its cells don’t reach their targets. In some cancers and rare immune deficiency disorders, immune cell levels are too low. X4 Pharmaceuticals has developed drugs that it says can help restore these counts to... Read more »
When automotive supplier Delphi forked over approximately $450 million to buy Boston-based software startup NuTonomy last month, it was the latest in a spate of high-dollar acquisitions involving companies that develop self-driving technologies. NuTonomy, founded by MIT researchers, was only four... Read more »
We start this week’s Boston tech watch on a somber note: Vanu Bose, a local technology executive and MIT alumnus, passed away Saturday from a sudden pulmonary embolism, according to an announcement from MIT. He was 52.
Bose was the founder... Read more »
Austin—The product is warm cookies, and the service is delivering those made-to-order sweets within 90 minutes. That can only happen with customized proprietary software, says Tiff’s Treats co-founder Leon Chen.
“The technology is the brains behind each of our locations,”... Read more »
Something rare happened this morning: A company that has gone through an accelerator program, SendGrid, has hit the public markets.
SendGrid raised $131 million by selling 8.2 million shares for $16 apiece, according to research firm Renaissance Capital. Both figures were... Read more »
CarGurus’ stock price is up around 10 percent Wednesday after the company delivered positive financial results in its first quarterly report since going public.
The Cambridge, MA-based software company’s stock (NASDAQ: CARG) was trading just under $33 per share as... Read more »
Acorda Therapeutics’ rebuilding plan just suffered another setback, leaving the fate of one of the experimental Parkinson’s disease drugs that is closest to market unclear.
Ardsley, NY-based Acorda (NASDAQ: ACOR) said Wednesday morning that it has seen troubling safety problems... Read more »
A Bose side project in the automotive industry will get new life in the hands of a new owner.
ClearMotion, a heavily funded MIT spinout working to commercialize technology aimed at making bumpy car rides go more smoothly, announced Wednesday... Read more »